This session will discuss the use of telemedicine by the University of Virginia Department of Psychiatry to provide clinical care to primary care agency patients in Southwest Virginia. Consultation and collaborative models of care will be presented, along with a discussion of the strengths and challenges of this technology for treatment of mental health problems. Since 2007, UVA and Clinch River Health Services have contracted to provide psychiatric evaluation and medication management for Dungannon patients. The psychiatric and primary care providers will present a case study illustrating the application of the collaborative model, and discuss the emerging questions related to expansion of this important access to care for rural Virginians.
This session will discuss the use of telemedicine by the University of Virginia Department of Psychiatry to provide clinical care to primary care agency patients in Southwest Virginia. Consultation and collaborative models of care will be presented, along with a discussion of the strengths and challenges of this technology for treatment of mental health problems. Since 2007, UVA and Clinch River Health Services have contracted to provide psychiatric evaluation and medication management for Dungannon patients. The psychiatric and primary care providers will present a case study illustrating the application of the collaborative model, and discuss the emerging questions related to expansion of this important access to care for rural Virginians.
Introduction to Depressive Disorders in Children and AdolescentsStephen Grcevich, MD
These slides accompany the didactic lectures Dr. Stephen Grcevich presented to child and adolescent psychiatry fellows at Akron Children's Hospital in September 2020. Topics covered include:
Session One: Epidemiology, presentation throughout childhood/adolescence, clinical course, risk factors, etiology
Session Two: Evaluation – diagnostic criteria, differential diagnosis, comorbidity, use of rating scales
Session Three: Pharmacotherapy and other medical treatments
Session Four: Non-pharmacologic treatments
PPD is similar to clinical depression.it is not only prevalent among women but also in men. sufferers are not alone and they can prevent this by talk, talk and talk.
This poster was presented to highlight the following mental health conditions in adolescent patients: attention deficit/hyperactivity disorder (ADD/ADHD), oppositional defiant disorder (ODD), and conduct disorder (CD).
Mental Health is a very important aspect of public health. Although mental health assessment is vital within all populations, it is especially vital to assess mental health within our vulnerable populations (e.g. adolescents)
Introduction to Depressive Disorders in Children and AdolescentsStephen Grcevich, MD
These slides accompany the didactic lectures Dr. Stephen Grcevich presented to child and adolescent psychiatry fellows at Akron Children's Hospital in September 2020. Topics covered include:
Session One: Epidemiology, presentation throughout childhood/adolescence, clinical course, risk factors, etiology
Session Two: Evaluation – diagnostic criteria, differential diagnosis, comorbidity, use of rating scales
Session Three: Pharmacotherapy and other medical treatments
Session Four: Non-pharmacologic treatments
PPD is similar to clinical depression.it is not only prevalent among women but also in men. sufferers are not alone and they can prevent this by talk, talk and talk.
This poster was presented to highlight the following mental health conditions in adolescent patients: attention deficit/hyperactivity disorder (ADD/ADHD), oppositional defiant disorder (ODD), and conduct disorder (CD).
Mental Health is a very important aspect of public health. Although mental health assessment is vital within all populations, it is especially vital to assess mental health within our vulnerable populations (e.g. adolescents)
Conduct disorder (CD) is a psychological disorder, sometimes also referred to as a behavioural disorder. This disorder is often diagnosed during childhood or adolescence.
Mental Health Conditions Among Children – A Growing ProblemSastasundar
Mental disorders in children are quite common, occurring in about one-quarter of this age group in any given year. The most common childhood mental disorders are anxiety disorders, depression, and attention deficit hyperactivity disorder (ADHD).
Conduct disorder is an ongoing pattern of behaviour marked by emotional and behavioural problems.
Ways in which Children with conduct disorder behave are
Angry,
Aggressive,
Argumentative, and
Disruptive ways.
It is a diagnosable mental health condition that is characterized by patterns of violating
Societal norms and
Rights of others
It's estimated that around 3% of school-aged children have conduct disorder and require professional treatment .
It is more common in boys than in girls.
Conduct disorder is a disorder of
childhood and adolescence that involves long-term (chronic) behavior problems,
such as:
Defiant or impulsive behavior
Drug use
Criminal activity
Children with conduct disorder may go on to
develop personality disorders as adults, particularly antisocial personality disorder. As their behaviors worsen, these individuals may
also develop drug and legal problems.
Depression and bipolar disorder may develop
in adolescence and early adulthood. Suicide and violence toward others are also
possible complications of this disorder.
An overview of Cluster B Personality Disorder. This presentation discusses the criteria, causes, prevalence and interventions for each personality disorders.
International Cancer Survivors Day is celebrated during June, placing the spotlight not only on cancer survivors, but also their caregivers.
CANSA has compiled a list of tips and guidelines of support:
https://cansa.org.za/who-cares-for-cancer-patients-caregivers/
Rate Controlled Drug Delivery Systems, Activation Modulated Drug Delivery Systems, Mechanically activated, pH activated, Enzyme activated, Osmotic activated Drug Delivery Systems, Feedback regulated Drug Delivery Systems systems are discussed here.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Letter to MREC - application to conduct studyAzreen Aj
Application to conduct study on research title 'Awareness and knowledge of oral cancer and precancer among dental outpatient in Klinik Pergigian Merlimau, Melaka'
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
2. Signs&Symptoms
Can range from mild to severe
Can interfere with
communication, daily
functioning, and quality of life
Can get worse if stressed or
anxious
Facial Grimacing
Excessive blinking, twitching, jerking,
coughing, throat clearing, grunting
Shrugging
Uncontrolled movements of legs and arms
Bending or twisting
Repeating observed movements
Obscene gesturing
Touching or smelling objects
Symptomseverity
3. What isthecause?
• The definite cause of the disorder is still unknown. Experts speculate
that it could be caused by physical and chemical abnormalities in the
brain. Nonetheless, the disorder is usually associated with contributing
factors, environmental, genetic, and sex.
• Genetics: The disorder tends to run in families with a history of
the condition thus hereditary. A genetic mutation in an
individual’s DNA is also a possible cause of motor tic disorder.
• Environmental factors: head trauma, maternal smoking,
childhood infections, pregnancy complications, low birth weight,
comorbid conditions, medication management, stress, lack of
sleep
• Sex: boys are at higher risk for tic disorders than girls
4. Ticsaretypically
diagnosedbased
onsymptoms
DIAGNOSING CHRONIC MOTOR TIC DISORDERS
The child must meet two of the following requirements for
the child to receive a chronic motor tic disorder diagnosis:
The tics must occur almost every day for more than a year.
The tics must be present without a tic-free period of longer
than 3 months.
The tics must have started before the age of 18.
Physical assessment
No test can diagnose the condition.
Information is gathered about the child’s symptoms from
parents or guardian and school teacher.
Your provider may order blood work to rule out other
conditions that might have symptoms similar to tics.
How is it diagnosed?
5. Thetreatmentapproach
The treatment approach is contingent on
various features, consisting of the degree,
regularity, and the degree of impairment
the tics cause in daily functioning.
Coexisting conditions should also be
identified as they can influence the efficacy
of the prescribed treatment course. School,
work, and social performance should also
be assessed to determine the level of
affliction, which helps govern the
treatment plan.
3rd line treatment
Severe impairment
Typical Antipsychotics
such as Haloperidol
2nd line treatment
Severe impairment
Atypical Antipsychotics
such as Risperidone
1st line treatment
Mild impairment:
Psychotherapy focus on
behavioral modification
TreatmentOptions
6. References
Black, K. J., Black, E. R., Greene, D. J., & Schlaggar, B. L. (2016). Provisional
Tic Disorder: What to tell parents when their child first starts
ticcing. F1000Research, 5, 696. https://doi.org/10.12688/f1000research.8428.1
Black, K. J., Kim, S., Schlaggar, B. L., & Greene, D. J. (2020). The New Tics
study: A novel approach to pathophysiology and cause of tic disorders. Journal
of psychiatry and brain science, 5.
Sadock, B. J., Sadock, V. A., & Ruiz, P. (2014). Kaplan & Sadock’s synopsis of
psychiatry: Behavioral sciences/clinical psychiatry (11th ed.). Philadelphia, PA:
Wolters Kluwer.